私募股权收购医院肺切除术后结局较差
该研究纳入2016-2020年接受择期肺切除的65-99岁Medicare受益人144,223例,其中11,140例(7.7%)在私募股权收购医院手术。风险调整后,收购医院30天死亡率、严重并发症、再入院率更高,术后住院更长,失败救助率无差异。
要点
- 私募股权收购医院肺切除年手术量更低(均数4.2对10.5,P<.001)。
- 收购医院30天死亡率2.1%对1.9%,OR 1.17(1.03-1.33),P=.019。
- 收购医院严重并发症8.1%对6.8%,OR 1.29(1.19-1.39),P<.001。
核心结论
- 私募股权收购医院行肺切除患者的30天死亡率、严重并发症和再入院率更高,术后住院更长。
研究设计与样本
- 回顾性队列研究,纳入2016-2020年65-99岁Medicare受益人择期肺切除144,223例。
- 私募股权收购医院通过AHRQ Health System Compendium识别,采用logistic回归风险调整比较结局。
主要发现
- 11,140例(7.7%)在私募股权收购医院接受肺切除。
- 收购医院肺切除年手术量均数4.2,非收购医院均数10.5,P<.001。
- 30天死亡率2.1%对1.9%,OR 1.17(1.03-1.33),P=.019。
- 严重并发症8.1%对6.8%,OR 1.29(1.19-1.39),P<.001。
- 30天再入院10.6%对9.9%,OR 1.08(1.01-1.15),P=.028;术后住院5.9天对5.3天,P<.001。
临床怎么用
- 心胸外科医生应关注私募股权收购医院的胸外科手术质量与结构因素。
- 对肺切除患者选择机构时,可参考医院年手术量与术后结局数据。
局限性
- 失败救助率无显著差异(9.8%对9.4%,OR 1.05(0.90-1.23),P=.518)。
- 原文未报告其他局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Private equity acquisition of hospitals performing complex operations is increasingly prevalent in the US healthcare landscape. Although comparative health outcomes for common medical conditions have been investigated, the quality of thoracic surgical care in private equity-acquired hospitals is unknown. METHODS: Medicare beneficiaries, aged 65 to 99 years, undergoing elective lung resection between 2016 and 2020 were included. Private equity-acquired hospitals were identified using the Agency for Healthcare Research and Quality Health System Compendium. Postoperative outcomes, including 30-day mortality, complications, failure to rescue, readmission, and postoperative length of stay were risk adjusted and compared with nonacquired hospitals using logistic regression considering patient age, sex, comorbidities, procedure type, and year of procedure. RESULTS: Of 144,223 beneficiaries undergoing lung resection, 11,140 (7.7%) received care at private equity-acquired hospitals. Private equity-acquired hospitals performed fewer lung resections annually (mean = 4.2) than nonacquired hospitals (mean = 10.5; P < .001). Compared with nonacquired hospitals, patients treated at private equity-acquired hospitals demonstrated higher rates of 30-day mortality (2.1% vs 1.9%, odds ratio [OR], 1.17 [1.03-1.33]; P = .019), serious complications (8.1% vs 6.8%, OR, 1.29 [1.19-1.39]; P < .001), 30-day readmission (10.6% vs 9.9%, OR, 1.08 [1.01-1.15]; P = .028), and longer postoperative length of stay (5.9 vs 5.3 days; P < .001). Failure-to-rescue rates were not significantly different (9.8% vs 9.4%, OR, 1.05 [0.90-1.23]; P = .518). CONCLUSIONS: These findings raise concern that private equity-acquired hospitals may provide lower-quality care for patients undergoing common thoracic procedures. Underlying structural factors may contribute to these differences. This motivates further investigation of specialty surgical care performed at private equity-acquired health institutions.
引用
- Williams JE, Schaefer SL, Jacobs RC, et al. Postoperative outcomes following lung resection performed at private equity-acquired hospitals. J Thorac Cardiovasc Surg. 2025. PMID: 39824345. doi:10.1016/j.jtcvs.2024.12.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。